Overcoming CAR T Cell Limitations: Membrane-Tethered SLP-76 Enhances Cancer Immunotherapy Against Low-Antigen Tumors
The Challenge of Antigen-Low Resistance in CAR T Cell Therapy Chimeric antigen receptor (CAR) T cell therapy has revolutionized cancer…